1. Pembrolizumab cutaneous adverse events and their association with disease progression;Sanlorenzo;JAMA Dermatol,2015
2. Debilitating skin toxicity associated with pembrolizumab therapy in an 81-year-old female with malignant melanoma;Khokhar;Case Rep Oncol,2016
3. Proliferative CD8(+) PD-1(+) T-cell infiltration in a pembrolizumab-induced cutaneous adverse reaction;Kunimasa;Invest New Drugs,2018
4. Revisiting cutaneous adverse reactions to pemetrexed;Piérard-Franchimont;Oncol Lett,2011
5. Mandatory dexamethasone strictly monitored by pharmacists reduces the severity of pemetrexed-induced skin rash;Usui;Eur J Hosp Pharm Sci Pract,2017